Article

A Clinical Perspective on Sudden Cardiac Death

Register or Login to View PDF Permissions
Permissions× For commercial reprint enquiries please contact Springer Healthcare: ReprintsWarehouse@springernature.com.

For permissions and non-commercial reprint enquiries, please visit Copyright.com to start a request.

For author reprints, please email rob.barclay@radcliffe-group.com.

  • Views: 2540

  • Likes: 0

  • Downloads: 29

  • Citations: 44

Average (ratings)
No ratings
Your rating

Abstract

This article presents the epidemiology, aetiology and pathophysiology of sudden cardiac death. The modern management of survivors as well as of family members of victims is discussed, as are the relevant recommendations of guidelines prepared by learned societies.

Keywords

Out-of-hospital cardiac arrest, sports-related sudden death, sudden cardiac death, sudden unexplained death syndrome,

Disclosure:The authors have no conflicts of interest to declare.

Received:

Accepted:

DOI:https://doi.org/10.15420/aer.2016:11:2

Acknowledgements:Andrew Grace, Section Editor– Arrhythmia Mechanisms/Basic Science acted as Editor for this article. This article is a modified excerpt from Ch.68: Sudden Cardiac Death from ‘Clinical Cardiology: Current Practice Guidelines’ edited by Katritsis, Gersh, & Camm (2016): Oxford University Press, with kind permission. © Oxford University Press, 2016.

Correspondence Details:Dr D Katritsis, Athens Euroclinic, 9 Athanassiadou Street, Athens 11521, Greece; E: dkatrits@dgkatritsis.gr and dkatrits@bidmc.harvard.edu

Copyright Statement:

The copyright in this work belongs to Radcliffe Medical Media. Only articles clearly marked with the CC BY-NC logo are published with the Creative Commons by Attribution Licence. The CC BY-NC option was not available for Radcliffe journals before 1 January 2019. Articles marked ‘Open Access’ but not marked ‘CC BY-NC’ are made freely accessible at the time of publication but are subject to standard copyright law regarding reproduction and distribution. Permission is required for reuse of this content.

Sudden cardiac death (SCD) is usually defined as death due to cardiac causes occurring within 1 hour of the onset of symptoms. Unexplained sudden death occurring in an individual older than 1 year of age is known as 'sudden unexplained death syndrome'. Unexplained sudden death occurring in an individual younger than 1 year of age is known as 'sudden unexplained death in infancy'. SCD with negative pathological and toxicological assessment is termed 'sudden arrhythmic death syndrome'.1

Epidemiology

In 2011, approximately 365,500 people (approximately 0.1 % of the population) experienced emergency medical services-assessed out-of-hospital cardiac arrests in the United States.2,3 Of the 19,300 bystander-witnessed out-of-hospital cardiac arrests that year, 31.4 % of victims survived. The annual incidence of SCD increases as a function of advancing age, being 100-fold less frequent in individuals <30 years of age (0.001 %) than it is in adults >35 years.4,5 There is a similar incidence in Europe, with reports of out-of-hospital cardiac arrest ranging from 0.04 % to 0.1 %.6–8 When the aetiological definition is limited to coronary artery disease (CAD) and its tachyarrhythmic burden, the estimate is <200,000 events per year.9

Approximately 50 % of all cardiac deaths are sudden, and this proportion has remained unchanged despite the overall decrease in cardiovascular mortality in recent decades. The proportion of all natural deaths due to SCD is 13 %; if a definition of 24 hours from onset of symptoms is used, it increases to 18.5 %.9 Analysis of data from the Department of Defense Cardiovascular Death Registry in the United States reveals that the incidence of sudden unexplained death per 100,000 person-years is 1.2 for persons aged 18–35 years and 2.0 for those >35 years of age.10 The numbers are higher in the King County (Washington) Cardiac Arrest Database, being 2.1 for infants of 0–2 years, 0.61 for children aged 3–13 years, 1.44 for young people aged 14–24 years and 4.4 for 25–35-year-olds, respectively.11 In the Oregon Sudden Unexpected Death Study, the annual incidence of sudden cardiac arrest among blacks was more than twofold higher than in whites for both men and women.12 In Denmark, the annual incidence of SCD is 2.3 for people aged 1–35 years and 21.7 for people aged 36–49 years.6 Population movement, and especially major train stations, are associated with a higher risk of SCD.13

The main problem with SCD is that the majority of out-of-hospital sudden cardiac arrests occur among patients in whom cardiac arrest is the first clinical expression of the underlying disease or those in whom disease has previously been identified but classified as low risk.9 There is an inverse relationship between incidence and absolute numbers of events, indicating that a large portion of the total population burden emerges from subgroups with lower risk indexes,9 thus making the identification and prevention of future events particularly difficult.

The incidence of sports-related sudden death from any cause in the general population is 0.5–2.1 per 100,000 per year.8,14–16 Although the vast majority of such cases occur during middle age, they represent a relatively small proportion (5 %) of overall sudden cardiac arrest cases.17 The sports-related sudden death rate is higher in elite athletes, with a reported incidence of 1:8,253 participants per year in the National Collegiate Athletic Association (NCAA). Among NCAA division I male basketball players, the incidence is 1:5,200 per year.16 In other studies, the reported incidence of SCD ranges from 0.24 to 3.8 per 100,000, with higher rates seen in African and Afro-Caribbean athletes.18–20,21

Aetiology

CAD is the most common underlying cause of SCD in the Western world, being responsible for 75–80 % of cases; cardiomyopathies and genetic channelopathies account for most of the remainder (see Table 1).6,22 SCD accounts for 50 % of all CAD-related deaths.9 The incidence of SCD-related atherosclerotic CAD is 0.7 per 100,000 person-years in 18–35-year-olds, increasing to 13.7 per 100,000 in those >35 years of age.10 Female survivors of cardiac arrest are less likely to have underlying CAD (45 %); valve disease and dilated or arrhythmogenic cardiomyopathy are more common.23

Article image
Download

Following acute myocardial infarction there is increased risk of SCD during the first months due to tachyarrhythmias or other complications such as re-infarction or myocardial rupture,24 and myocardial scar predisposes to monomorphic ventricular tachycardia (VT). Apart from patients with ST-segment elevation, patients resuscitated from a shockable rhythm should be subjected to coronary angiography.25–27 Although most patients with a cardiac arrest have demonstrable CAD, however, less than half seem to have suffered an acute myocardial infarction.28,29 Only 38 % of cardiac arrest survivors develop evidence of myocardial infarction,22 and the use of tenecteplase during advanced life support for out-of-hospital cardiac arrest does not improve outcomes.30

The most common causes of non-ischaemic SCD are currently cardiomyopathy related to obesity or alcoholism and fibrotic cardiomyopathy.31

In patients with preserved ejection fraction in the Cardiac Arrest Survivors with Preserved Ejection Fraction Registry (CASPER), an aetiological diagnosis was possible in approximately half of cardiac arrest survivors, the rest being considered cases of idiopathic ventricular fibrillation (VF), presumably due to intrinsic electric abnormalities such as early repolarisation.32 A resuscitated cardiac arrest victim, preferably with documentation of VF, in whom known cardiac, respiratory, metabolic and toxicological aetiologies have been excluded through clinical evaluation is considered to have idiopathic VF.1 Several ion-channel and gene-coding mutations have been associated with idiopathic VF.33 Genetic testing diagnoses an inherited arrhythmia (genetic channelopathy) in up to 29 % of families where a relative has died due to SCD.34 Several studies have also demonstrated a familial predisposition to SCD that may or may not be related to genetic channelopathies.35–37

Coronary spasm is also a cause of cardiac arrest, particularly in male smokers with minimal or no pre-existing CAD.38 Mitral valve prolapse in female patients with ECG repolarisation abnormalities, and frequent complex ventricular ectopy, has also been associated with out-of-hospital cardiac arrest.39,40 An association between air pollution (fine particulate matter with an aerodynamic diameter <2.5 µm and ozone) and out-of-hospital cardiac arrest has recently been demonstrated.41 SCDs account for most cardiac and many non-AIDS-related natural deaths in HIV-infected patients.42 Lower socioeconomic status, depression, anxiety, social isolation and acute emotional stress have all been linked to increased SCD risk.43,44

There is a circadian variation in SCD. The peak incidence of SCD occurs between 6 am and noon (and is blunted by beta-blockers), with a smaller peak occurring in the late afternoon for out-of-hospital VF arrests. The incidence is highest on Mondays.45,46

In the young (<35 years), the most common cause of SCD is arrhythmia, mostly in the context of an apparently normal heart.11,47 The most common causes of SCD are congenital abnormalities in those aged 0–13 years, primary arrhythmia in the 14–24-year age group, and CAD in those >25 years.11 In 5–20 % of cases no significant cardiac abnormality is found at autopsy.10,47 In a recent Danish registry report on individuals aged <50 years, sudden death was caused by noncardiac diseases, such as pulmonary embolism, meningitis and cerebrovascular bleeding, in 28 % of cases.48

In sports-related sudden death in the general population, a clear diagnosis is made in <25 % of cases, but the cause is usually an acute coronary syndrome (75 %).14 In professional athletes, a diagnosis is usually made in up to 65 % of cases and hypertrophic cardiomyopathy (HCM) is considered the main cause, at least in the United States, followed by arrhythmogenic right ventricular cardiomyopathy (ARVC, especially in the Veneto region of Italy), congenital coronary anomalies, genetic channelopathies, myocarditis, Wolff–Parkinson–White syndrome and Marfan syndrome, with blunt trauma, commotio cordis and heat stroke being less frequent causes.19,49,50 There is evidence, however, that HCM may not be the major cause of SCD in athletes.16,20 Autopsies in deceased NCAA athletes most often reveal a structurally normal heart (25 %), followed by coronary artery anomalies (11 %), myocarditis (9 %), ARVC (5 %) and aortic dissection (5 %), with HCM only demonstrated in 8 % of individuals.16 Findings from the Race Associated Cardiac Arrest Event Registry (RACER) indicate that marathons and half marathons are associated with a low overall risk of cardiac arrest or sudden death (1:100,000), with deaths most commonly attributable to HCM (26 %) or atherosclerotic coronary disease (16 %).45 Some of these cardiac arrests might, however, have been provoked by heat stroke.51 CAD is the predominant cause of SCD in older athletes.52 Vigorous exertion can trigger cardiac arrest or SCD, especially in untrained persons, but habitual vigorous exercise diminishes the risk of sudden death during vigorous exertion.53 Most studies have found inverse associations between regular physical activity and SCD.22

Article image
Download

Pathophysiology

VT or VF was thought to be the most common cause of out-of-hospital cardiac arrest, accounting for approximately three-quarters of cases,the remaining 25 % being caused by bradyarrhythmias or asystole.54,55 More recent studies, however, suggest that the incidence of VF or pulseless VT as the first recorded rhythm in out-of-hospital cardiac arrest has declined to <30 % in the past few decades.56–58 Pulseless electrical activity (electromechanical dissociation) and asystole are proportionally more frequent mechanisms than VT/VF. Recent data demonstrate a pulseless electrical activity incidence of 19–23 %, with approximately 50 % of patients initially having asystole.59 However, the majority of survivors are in the subgroup whose initial rhythm is VF or pulseless VT.57 VF is a cause of cardiac arrest, and if untreated the arrhythmia is usually fatal. Spontaneous reversions to sinus rhythm have, however, been recorded. Non-arrhythmic mechanisms, such as myocardial rupture or aortic aneurysm rupture, may also result in SCD.

Article image
Download

Article image
Download

Investigations in Survivors

Overall survival after out-of-hospital cardiac arrest remains low, at approximately 7.6 %,60 but survivors’ quality of life is good for at least for the next 12 months.61 Early coronary angiography in patients resuscitated as a result of a shockable rhythm with immediate percutaneous coronary intervention improves survival.26,27

A full cardiac assessment is needed in cardiac arrest survivors.38 Patients presenting with VF or sustained monomorphic VT are at a considerable risk of recurrence, particularly in the presence of reduced left ventricular function. Studies of out-of-hospital cardiac arrest survivors as well as of patients with sustained VT have shown that the actuarial incidence of sudden death 2 years after the presenting arrhythmia varies from 15 % to 30 %. Up to 74 % of patients with out-of-hospital cardiac arrest have VF recurrence during prehospital care, and the time in VF is associated with a worse outcome.62 Long-term survival among patients who have undergone rapid defibrillation after out-of-hospital cardiac arrest, however, is similar to that among age-, sex- and disease-matched patients who have not had out-of-hospital cardiac arrest, although only 40 % of survivors had an implantable cardioverter defibrillator implanted.63

Family members of young SCD victims are at increased risk for ventricular arrhythmias and ischaemic heart disease. Screening of first-degree relatives, especially those <35 years old, is important.64 When findings suggest cardiomyopathy or genetic channelopathy, the evaluation of other family members is also necessary. The examination of relatives (cascade family screening) may have a significant diagnostic yield.65 It should be noted, however, that no reported history of sudden death among the relatives of most young (<35 years) decedents may be identified.47 Investigation into the genetic basis of SCD, such as the candidate gene approach, has explored the potential association between SCD in CAD and genes associated with genetic channelopathies. Genome-wide association studies are promising but of limited clinical value.9

The following tests are useful for establishing a diagnosis in SCD survivors:38

  • ECG (ischaemia, myocardial infarction, inherited channelopathies).
  • Echocardiography (heart failure, cardiomyopathies, valve disease, congenital heart disease).
  • Coronary angiography (CAD, congenital coronary anomalies, coronary spasm).
  • Exercise test (ischaemia, long QT syndrome [LQTS], catecholaminergic polymorphic ventricular tachycardia [CPVT]).
  • Electrophysiology testing (induction of arrhythmia, pharmacological provocation for Brugada syndrome, LQTS, CPVT). Procainamide testing may provoke a Brugada pattern irrespective of the baseline ECG and should be considered in the workup of SCD.66
  • Cardiac MRI (ARVC, sarcoidosis, myocarditis, myocardial injury from coronary spasm).
  • Genetic testing is indicated when an inherited phenotype is detected (ARVC, Brugada syndrome, CPVT, LQTS). Its role in phenotypicallyambiguous or -negative patients is not established, since it is not always possible to differentiate between disease-causing mutations and irrelevant genetic variants. The recommendations for genetic testing are presented in Table 2.
  • Cardiac biopsy may also be needed in elusive cases.

A molecular autopsy may also be considered as part of the community forensic investigation to enhance SCD prevention for other family members (see Table 3). Thus, in cases of documented SCD without an obvious cause, collection of post-mortem blood in ethylenediaminetetraacetic acid, i.e. the purple-top tube to enable DNA extraction, for subsequent DNA analysis may identify a cause of death in up to 30 % of cases.67 A forensic examination, including a toxicology screen, may establish the diagnosis in cases of traumatic, toxic or cardiac causes. A negative pathological examination suggests a genetic channelopathy.68 Post-mortem MRI is also a valuable tool for non-invasively documenting pathological findings, such as myocardial infarction or severe myocardial hypertrophy,69 and post-mortem computed tomography coronary angiography is now possible.70 Despite every effort, however, nearly half of the causes of cardiac arrest will remain unexplained.32

Management of Cardiac Arrest

A population-based cohort study on out-of-hospital cardiac arrest survivors in Ontario, Canada, detected an improved 30-day survival from 9.4 % in 2002 to 13.6 % in 2011.71 Survival is better in places with facilities for bystander resuscitation.15 Defibrillators in public locations (Table 4), such as train stations,13 however, only reduce the incidence of SCD when the local population is trained to use them.72 Recent data from the United States Cardiac Arrest Registry to Enhance Survival (CARES) suggest that rates of survival following out-of-hospital cardiac arrest have improved among sites participating in a performanceimprovement registry.73 Improved survival rates are more prominent in patients aged 18–80 years.74

Clinical Implications

The annual incidence of SCD increases as a function of advancing genetic channelopathies account for most of the remaining cases. In the young (<35 years), the most common cause of SCD is arrhythmias, mostly in the context of an apparently normal heart. In sports-related sudden death in the general population, a clear diagnosis is made in <25 % of cases, but the cause is usually an acute coronary syndrome (75 %). Examination of relatives (cascade family screening) may have a significant diagnostic yield and is strongly recommended.

References

  1. Priori SG, Wilde AA, Horie M, et al. HRS/EHRA/APHRS expert consensus statement on the diagnosis and management of patients with inherited primary arrhythmia syndromes: document endorsed by HRS, EHRA, and APHRS in May 2013 and by ACCF, AHA, PACES, and AEPC in June 2013. Europace 2013;10:1932–63.
    Crossref | PubMed
  2. Fishman GI CS, Dimarco JP, Albert CM, et al. Sudden cardiac death prediction and prevention: Report from a National Heart, Lung, and Blood Institute and Heart Rhythm Society workshop. Circulation 2010;122:2335–48.
    Crossref | PubMed
  3. Mozaffarian D, Benjamin EJ, Go AS, et al.; American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics – 2015 update: A report from the American Heart Association. Circulation 2015;131 :e29–322.
    Crossref | PubMed
  4. Stecker EC, Reinier K, Marijon E, et al. Public health burden of sudden cardiac death in the United States. Circ Arrhythm Electrophysiol 2014;7:212–7.
    Crossref | PubMed
  5. Kong MH, Fonarow GC, Peterson ED, et al. Systematic review of the incidence of sudden cardiac death in the United States. J Am Coll Cardiol 2011;57:794–801
    Crossref | PubMed
  6. Risgaard B, Winkel BG, Jabbari R, et al. Burden of sudden cardiac death in persons aged 1 to 49 years: Nationwide study in Denmark. Circ Arrhythm Electrophysiol 2014;7:205–11.
    Crossref | PubMed
  7. de Vreede-Swagemakers JJ, Gorgels AP, Dubois-Arbouw WI, et al. Out-of-hospital cardiac arrest in the 1990’s: A populationbased study in the Maastricht area on incidence, characteristics and survival. J Am Coll Cardiol 1997;30:1500–5.
    Crossref | PubMed
  8. Berdowski J,. de Beus MF, Blom M, et al. Exercise-related outof-hospital cardiac arrest in the general population: incidence and prognosis. Eur Heart J 2013;34:3616–23.
    Crossref | PubMed
  9. Myerburg RJ, Junttila MJ. Sudden cardiac death caused by coronary heart disease. Circulation 2012;125:1043–52.
    Crossref | PubMed
  10. Eckart RE, Shry EA, Burke AP, et al,. Sudden death in young adults: an autopsy-based series of a population undergoing active surveillance. J Am Coll Cardiol 2011;58:1254–61.
    Crossref | PubMed
  11. Meyer L, Stubbs B, Fahrenbruch C, et al. Incidence, causes, and survival trends from cardiovascular-related sudden cardiac arrest in children and young adults 0 to 35 years of age: a 30-year review. Circulation 2012;126:1363–72.
    Crossref | PubMed
  12. Reinier K NG, Huertas-Vazquez A, Uy-Evanado A, et al. Distinctive clinical profile of blacks versus whites presenting with sudden cardiac arrest. Circulation. 2015;132:380–7.
    Crossref | PubMed
  13. Marijon E, Bougouin W, Tafflet M, et al. Population movement and sudden cardiac arrest location. Circulation 2015;131:1546–54.
    Crossref | PubMed
  14. Marijon E, Tafflet M, Celermajer DS, et al. Sports-related sudden death in the general population. Circulation 2011;124:672–81.
    Crossref | PubMed
  15. Marijon E, Bougouin B, Celermajer DS, et al. Major regional disparities in outcomes after sudden cardiac arrest during sports. Eur Heart J 2013;34:3632–40.
    Crossref | PubMed
  16. Harmon KG, Asif IM, Maleszewski JJ, et al. Incidence, etiology, and comparative frequency of sudden cardiac death in NCAA athletes: a decade in review. Circulation 2016;134.
    Crossref
  17. Marijon E, Uy-Evanado A, Reinier K, et al. Sudden cardiac arrest during sports activity in middle age. Circulation 2015;131 :1384–91.
    Crossref | PubMed
  18. Maron BJ, Haas TS, Murphy CJ, et al. Incidence and causes of sudden death in U.S. College athletes J Am Coll Cardiol 2014;63:1636–43.
    Crossref | PubMed
  19. Chandra N, Bastiaenen R, Papadakis M, et al. Sudden cardiac death in young athletes: practical challenges and diagnostic dilemmas. J Am Coll Cardiol 2013;61 :1027–40. 
    Crossref | PubMed
  20. Holst AG, Winkel BG, Theilade J, et al. Incidence and etiology of sports-related sudden cardiac death in Denmark – implications for preparticipation screening. Heart Rhythm 2010;7:1365–71. 
    Crossref | PubMed
  21. Roberts WO, Stovitz SD. Incidence of sudden cardiac death in Minnesota high school athletes 1993-2012 screened with a standardized preparticipation evaluation. J Am Coll Cardiol 2013;62:1298–1.
    Crossref | PubMed
  22. Deo R, Albert CM. Epidemiology and genetics of sudden cardiac death. Circulation 2012;125:620–37.
    Crossref | PubMed
  23. Albert CM, McGovern BA, Newell JB, et al. Sex differences in cardiac arrest survivors. Circulation 1996;93:1170–6.
    Crossref | PubMed
  24. Pouleur AC, Barkoudah E, Uno H, et al. Pathogenesis of sudden unexpected death in a clinical trial of patients with myocardial infarction and left ventricular dysfunction, heart failure, or both. Circulation 2010;122:597–602.
    Crossref | PubMed
  25. Rab T, Kern KB, Tamis-Holland JE, et al.; Interventional Council, American College of Cardiology. Cardiac arrest: a treatment algorithm for emergent invasive cardiac procedures in the resuscitated comatose patient. J Am Coll Cardiol 2015;66:62–73.
    Crossref | PubMed
  26. Geri G, Dumas F, Bougouin W, et al. Immediate percutaneous coronary intervention is associated with improved shortand long-term survival after out-of-hospital cardiac arrest. Circ Cardiovasc Interv 2015;8:pii: e002303.
    Crossref | PubMed
  27. Vyas A, Chan PS, Cram P, et al. Early coronary angiography and survival after out-of-hospital cardiac arrest. Circ Cardiovasc Interv 2015;8.:pii:e002321.
    Crossref | PubMed
  28. Farb A, Tang AL, Burke AP, et al. Sudden coronary death. Frequency of active coronary lesions, inactive coronary lesions, and myocardial infarction. Circulation 1995;92:1701–9.
    Crossref | PubMed
  29. Kannel WB, Thomas HE, Jr. Sudden coronary death: the Framingham study. Ann N Y Acad Sci 1982;382:3–21.
    Crossref | PubMed
  30. Böttiger BW, Arntz HR, Chamberlain DA, et al.; TROICA Trial Investigators; European Resuscitation Council Study Group. Thrombolysis during resuscitation for out-of-hospital cardiac arrest. N Engl J Med. 2008;359:2651–62.
    Crossref | PubMed
  31. Hookana E, Junttila MJ, Puurunen VP, et al. Causes of nonischemic sudden cardiac death in the current era. Heart Rhythm 2011;8:1570–5.
    Crossref | PubMed
  32. Derval N SC, Birnie DH, Healey JS, et al. Prevalence and characteristics of early repolarization in the CASPER registry: Cardiac arrest survivors with preserved ejection fraction registry. J Am Coll Cardiol 2011;58:722–8.
    Crossref | PubMed
  33. Marsman RF, Barc J, Beekman L, et al. A mutation in CALM1 encoding calmodulin in familial idiopathic ventricular fibrillation in childhood and adolescence. J Am Coll Cardiol 2014;63:259–66.
    Crossref | PubMed
  34. Hofman N, Tan HL, Alders M, et al. Yield of molecular and clinical testing for arrhythmia syndromes: report of a 15 years’ experience. Circulation 2013;128:1513–21.
    Crossref | PubMed
  35. Crotti L, Hu D, Barajas-Martinez H, et al. Torsades de pointes following acute myocardial infarction: evidence for a deadly link with a common genetic variant. Heart Rhythm 2012;9: 1104–12.
    Crossref | PubMed
  36. Dekker LR, Bezzina CR, Henriques JP, et al. Familial sudden death is an important risk factor for primary ventricular fibrillation: a case-control study in acute myocardial infarction patients. Circulation 2006;114:1140–5.
    Crossref | PubMed
  37. Jouven X, Desnos M, Guerot C, et al. Predicting sudden death in the population: The Paris Prospective Study I. Circulation 1999;99:1978–83.
    Crossref | PubMed
  38. Modi S, Krahn AD. Sudden cardiac arrest without overt heart disease. Circulation 2011;123:2994–3008.
    Crossref | PubMed
  39. Sriram CS, Syed FF, Ferguson ME, et al. Malignant bileaflet mitral valve prolapse syndrome in patients with otherwise idiopathic out of hospital cardiac arrest. J Am Coll Cardiol 2013;62:222–30.
    Crossref | PubMed
  40. Basso C, Perazzolo Marra M, Rizzo S, et al. Arrhythmic mitral valve prolapse and sudden cardiac death. Circulation 2015;132:556–66.
    Crossref | PubMed
  41. Ensor KB, Raun LH, Persse D. A case-crossover analysis of out-of-hospital cardiac arrest and air pollution. Circulation 2013;127:1192–9.
    Crossref | PubMed
  42. Tseng ZH, Secemsky EA, Dowdy D, et al. Sudden cardiac death in patients with human immunodeficiency virus infection. J Am Coll Cardiol 2012;59:1891–6.
    Crossref | PubMed
  43. Empana JP, Jouven X, Lemaitre RN, et al. Clinical depression and risk of out-of-hospital cardiac arrest. Arch Intern Med. 2006;166: 195–200.
    Crossref | PubMed
  44. Leor J, Poole WK, Kloner RA. Sudden cardiac death triggered by an earthquake. N Engl J Med. 1996;334:413–9.
    Crossref | PubMed
  45. Kim JH, Malhotra R, Chiampas G, et al. Cardiac arrest during long-distance running races. N Engl J Med. 2012;366:130–40.
    Crossref | PubMed
  46. Arntz HR, Willich SN, Schreiber C, et al. Diurnal, weekly and seasonal variation of sudden death. Population-based analysis of 24,061 consecutive cases. Eur Heart J 2000;21 : 315–20.
    Crossref | PubMed
  47. Puranik R, Chow CK, Duflou JA, et al. Sudden death in the young. Heart Rhythm 2005;2:1277–82.
    Crossref | PubMed
  48. Risgaard B, Lynge TH, Wissenberg M, et al. Risk factors and causes of sudden noncardiac death: a nationwide cohort study in Denmark. Heart Rhythm 2015;12:968–74.
    Crossref | PubMed
  49. Maron BJ, Doerer JJ, Haas TS, et al. Sudden deaths in young competitive athletes: analysis of 1866 deaths in the United States, 1980–2006. Circulation 2009;119:1085–92.
    Crossref | PubMed
  50. Corrado D, Basso C, Pavei A, et al. Trends in sudden cardiovascular death in young competitive athletes after implementation of a preparticipation screening program. JAMA 2006;296:1593–601.
    Crossref | PubMed
  51. Yankelson L, Sadeh B, Gershovitz, et al. Life-threatening events during endurance sports: is heat stroke more prevalent than arrhythmic death? J Am Coll Cardiol 2014;64:463–9.
    Crossref | PubMed
  52. Chugh SS, Weiss JB. Sudden cardiac death in the older athlete. J Am Coll Cardiol 2015;65:493–502.
    Crossref | PubMed
  53. Albert CM, Mittleman MA, Chae CU, et al. Triggering of sudden death from cardiac causes by vigorous exertion. N Engl J Med 2000;343:1355–61. 
    Crossref | PubMed
  54. Bayés de Luna A, Coumel P, Leclercq JF. Ambulatory sudden cardiac death: mechanisms of production of fatal arrhythmia on the basis of data from 157 cases. Am Heart J 1989;117: 151–9.
    Crossref | PubMed
  55. Myerburg RJ, Kessler KM, Castellanos A. Sudden cardiac death. Structure, function, and time-dependence of risk. Circulation 1992;85:I2–10. 
    PubMed
  56. Cobb LA, Fahrenbruch CE, Olsufka M, et al. Changing incidence of out-of-hospital ventricular fibrillation, 1980–2000. JAMA 2002;288:3008–13.
    Crossref | PubMed
  57. Nichol G, Thomas E, Callaway CW, et al. Regional variation in out-of-hospital cardiac arrest incidence and outcome. JAMA 2008;300:1423–31.
    Crossref | PubMed
  58. Weisfeldt ML, Everson-Stewart S, Sitlani C, et al. Ventricular tachyarrhythmias after cardiac arrest in public versus at home. N Engl J Med 2011;364:313–21.
    Crossref | PubMed
  59. Myerburg RJ, Halperin H, Egan DA, et al. Pulseless electric activity: definition, causes, mechanisms, management, and research priorities for the next decade: Report from a national heart, lung, and blood institute workshop. Circulation 2013;128:2532–41.
    Crossref | PubMed
  60. Sasson C, Rogers MA, Dahl J, et al. Predictors of survival from out-of-hospital cardiac arrest: a systematic review and meta-analysis. Circ Cardiovasc Qual Outcomes 2010;3:63–81.
    Crossref | PubMed
  61. Smith K, Andrew E, Lijovic M, et al. Quality of life and functional outcomes 12 months after out-of-hospital cardiac arrest. Circulation 2015;131 :174–81.
    Crossref | PubMed
  62. Berdowski J, ten Haaf M, Tijssen JG, et al. Time in recurrent ventricular fibrillation and survival after out-of-hospital cardiac arrest. Circulation 2010;122:1101–8.
    Crossref | PubMed
  63. Bunch TJ, White RD, Gersh BJ, et al. Long-term outcomes of out-of-hospital cardiac arrest after successful early defibrillation. N Engl J Med 2003;348:2626–33.
    Crossref | PubMed
  64. Ranthe MF, Winkel BG, Andersen EW et al. Risk of cardiovascular disease in family members of young sudden cardiac death victims. Eur Heart J 2013;34:503–11.
    Crossref | PubMed
  65. Hofman N, Tan HL, Alders M, et al. Active cascade screening in primary inherited arrhythmia syndromes: does it lead to prophylactic treatment? J Am Coll Cardiol 2010;55:2570–6.
    Crossref | PubMed
  66. Somani R KA, Healey JS, Chauhan VS, et al. Procainamide infusion in the evaluation of unexplained cardiac arrest: from the Cardiac Arrest Survivors with Preserved Ejection Fraction Registry (CASPER). Heart Rhythm 2014;11 :1047–54.
    Crossref | PubMed
  67. Semsarian C, Ingles J, Wilde AAM. Sudden cardiac death in the young: the molecular autopsy and a practical approach to surviving relatives. Eur Heart J 2015;36:1290–6.
    Crossref | PubMed
  68. Basso C, Burke M, Fornes P, et al. Guidelines for autopsy investigation of sudden cardiac death. Pathologica 2010;102: 391–404.
    Crossref | PubMed
  69. Jackowski C, Schwendener N, Grabherr S, et al. Post-mortem cardiac 3-T magnetic resonance imaging: visualization of sudden cardiac death? J Am Coll Cardiol 2013;67:617–29.
    Crossref | PubMed
  70. Michaud K, Grabherr S, Doenz F, et al. Evaluation of postmortem MDCT and MDCT-angiography for the investigation of sudden cardiac death related to atherosclerotic coronary artery disease. Int J Cardiovasc Imaging 2012;28:1807–22.
    Crossref | PubMed
  71. Wong MK, Morrison LJ, Qiu F, et al. Trends in short- and longterm survival among out-of-hospital cardiac arrest patients alive at hospital arrival. Circulation 2014;130:1883–90.
    Crossref | PubMed
  72. Estes MNA. Predicting and preventing sudden cardiac death. Circulation 2011;124:651–6.
    Crossref | PubMed
  73. Chan PS, McNally B, Tang F, et al.; CARES Surveillance Group. Recent trends in survival from out-of-hospital cardiac arrest in the United States. Circulation 2014;130:1876–82.
    Crossref | PubMed
  74. Wissenberg M, Fokle F, Malta Hansen C, et al. Survival after out-of-hospital cardiac arrest in relation to age and early identification of patients with minimal chance of longterm survival. Circulation 2015;131 :1536–45.
    Crossref | PubMed
  75. Priori SG, Blomström-Lundqvist C, Mazzanti A, et al. 2015 ESC guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death. Eur Heart J 2015; 36:2793–867.
    Crossref | PubMed
Previous Volume Article Next Volume Article